Commercial: FDA / Vascepa | Vanderbilt Television News Archive

Commercial: FDA / Vascepa #1277479

CBS Evening News for Thursday, Jul 23, 2020
View other clips in this broadcast →

Material supplied by VTNA may be used for educational analysis or research only. Any editing, reproduction, publication, rebroadcast, public showing or public display may be prohibited by copyright laws.

Are you still at risk for a heart attack or stroke, even if you're on a statin? Statins may lower some risks, but may not be enough. That's why science delivered Vascepa for people who have persistent cardiovascular risk factors and take a step on the city's clinically proven to provide twenty five percent lower risk from heart attack and stroke. Don't take Vascepa if you're allergic to icassp and ethyl or any an active ingredient in Vascepa your doctor about any medicines you take and if you ar...

Duration:: 00:01:03

Note to sponsor members: The Vanderbilt Television News Archive video player requires a modern operating system and browser to work properly. If you are experiencing playback problems, check the minimum requirements and adjust your setup accordingly. After adjustments, if you continue to experience problems, please contact us.

Welcome! Above is the abstract of the item that you're interested in viewing from the Vanderbilt Television News Archive's collection. You have three options if you'd like to view this item:

You may request a loan of this video by registering on our website and placing an order.
You may visit the Television News Archive on the Vanderbilt campus to view on-site from the Archive's collection.
If you are associated with a college or university, you may ask your library if they would like to become a sponsor, which would give students and faculty at your institution the ability to view items from our collection.

If you believe that you are associated with a sponsoring college or university and have received this message in error, please let us know.